Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study - Clinical Trial Assessing Efficacy and Safety of the mTOR Inhibitor Sirolimus in the Treatment of Complicated Vascular Anomalies

NCT00975819 is registered in ClinicalTrials.gov with Denise Martin Adams as lead sponsor.

NCT NCT00975819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00975819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study - Clinical Trial Assessing Efficacy and Safety of the mTOR Inhibitor Sirolimus in the Treatment of Complicated Vascular Anomalies
Lead sponsor
Denise Martin Adams
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2009
Completion date
October 31, 2020
Enrollment
61 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

capillary lymphatic arterial venous malformations, capillary venous lymphatic malformation, kaposiform hemangioendotheliomas, lymphangiectasia syndromes, microcystic lymphatic malformation, mucocutaneous lymphangiomatosis and thrombocytopenia, pten overgrowth syndrome with vascular anomaly, tufted angioma, venous lymphatic malformation